⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Genfoquest Analytica and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Genfoquest Analytica
↗Izmir, Türkiye
Genfoquest Analytica is a bioinformatics and data science company based in Ege Teknopark, Izmir, Türkiye. The company specializes in providing analytical services, software, and platforms for multi-omics integration, target discovery, and preclinical decision support, particularly in the fields of immunotherapy and molecular medicine.
Founded in 2022, the firm focuses on turning complex biological data into actionable insights for life science organizations. Their platform stack includes tools for single-cell analysis (Single-cell Quest), surface antigen target evaluation (SurfACE-MT), and early toxicity risk assessment (Toxicome).
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Bioinformatics & Computational Biology
SIZE & FINANCIALS
Employees:1-50
Founded:2022
Ownership:private
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service/Platform Provider)
Modalities:Cell therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:BMGLab (Collaborative research projects)
COMPETITION
Position:Niche Player
LINKS
Website:genfoquest.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Genfoquest Analytica. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.